NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or violations of shareholder fiduciary duties related to:

LogicBio Therapeutics, Inc. LOGC‘s Sold to AstraZeneca Rare Disease for $2.07 per share. If you are a shareholder of LogicBio, Click here to learn more about your rights and options.

Imara Inc. IMRA‘s Merged with Enliven Therapeutics, Inc. If you are an Imara shareholder, Click here to learn more about your rights and options.

Silverback Therapeutics, Inc. SBTX‘s Merger with ARS Pharmaceuticals, Inc. Under the terms of the merger agreement, and assuming Silverback’s net cash position at closing is $240 million, Silverback shareholders are expected to own approximately 37% of the combined company. If you are a Silverback shareholder, Click here to learn more about your rights and options.

Shareholders are encouraged to contact the company for free to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors worldwide who have been victims of securities fraud and corporate wrongdoing. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

lawyer advertising. Previous results do not guarantee a similar result.

Contact information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com